# OnCo record fixed-duration (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/fixed-duration/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "fixed-duration" ;
  schema:name "Fixed-duration vs continuous therapy"@en ;
  schema:alternateName "fixed-duration"@en, "fixed duration"@en, "time-limited"@en, "time-limited therapy"@en, "finite therapy"@en, "continuous therapy"@en, "continuous treatment"@en, "indefinite treatment"@en, "treatment-free"@en, "treatment-free interval"@en, "treatment-free survival"@en, "off-treatment"@en, "treatment discontinuation"@en, "stopping rules"@en, "stop trial"@en, "treatment cessation"@en, "elective discontinuation"@en, "stopping rule"@en ;
  schema:description "Whether a drug is taken for a set period (say 12 months) and then stopped even though it is still working, or continued indefinitely until it fails. Fixed-duration gives patients years off treatment; continuous therapy avoids the risk of the cancer regrowing."@en ;
  schema:url <https://onco.cc/terms/fixed-duration/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Chronic_lymphocytic_leukemia#Treatment> ;
  schema:citation <https://en.wikipedia.org/wiki/Chronic_lymphocytic_leukemia#Treatment> ;
  onco:related <https://onco.cc/terms/umrd/>, <https://onco.cc/terms/molecular-response/>, <https://onco.cc/terms/maintenance-therapy/>, <https://onco.cc/terms/rechallenge/> ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/ibrutinib/> .